Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.
OBJECTIVE: Examine the relationship between antibodies to 25 oral bacteria and pancreatic cancer risk in a prospective cohort study. DESIGN: We measured antibodies to oral bacteria in prediagnosis blood samples from 405 pancreatic cancer cases and 416 matched controls, nested within the European Pro...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Journal article |
| שפה: | English |
| יצא לאור: |
2013
|
| _version_ | 1826267073310883840 |
|---|---|
| author | Michaud, D Izard, J Wilhelm-Benartzi, C You, D Grote, V Tjønneland, A Dahm, C Overvad, K Jenab, M Fedirko, V Boutron-Ruault, M Clavel-Chapelon, F Racine, A Kaaks, R Boeing, H Foerster, J Trichopoulou, A Lagiou, P Trichopoulos, D Sacerdote, C Sieri, S Palli, D Tumino, R Panico, S Siersema, P |
| author_facet | Michaud, D Izard, J Wilhelm-Benartzi, C You, D Grote, V Tjønneland, A Dahm, C Overvad, K Jenab, M Fedirko, V Boutron-Ruault, M Clavel-Chapelon, F Racine, A Kaaks, R Boeing, H Foerster, J Trichopoulou, A Lagiou, P Trichopoulos, D Sacerdote, C Sieri, S Palli, D Tumino, R Panico, S Siersema, P |
| author_sort | Michaud, D |
| collection | OXFORD |
| description | OBJECTIVE: Examine the relationship between antibodies to 25 oral bacteria and pancreatic cancer risk in a prospective cohort study. DESIGN: We measured antibodies to oral bacteria in prediagnosis blood samples from 405 pancreatic cancer cases and 416 matched controls, nested within the European Prospective Investigation into Cancer and Nutrition study. Analyses were conducted using conditional logistic regression and additionally adjusted for smoking status and body mass index. RESULTS: Individuals with high levels of antibodies against Porphyromonas gingivalis ATTC 53978, a pathogenic periodontal bacteria, had a twofold higher risk of pancreatic cancer than individuals with lower levels of these antibodies (OR 2.14; 95% CI 1.05 to 4.36; >200 ng/ml vs ≤200 ng/ml). To explore the association with commensal (non-pathogenic) oral bacteria, we performed a cluster analysis and identified two groups of individuals, based on their antibody profiles. A cluster with overall higher levels of antibodies had a 45% lower risk of pancreatic cancer than a cluster with overall lower levels of antibodies (OR 0.55; 95% CI 0.36 to 0.83). CONCLUSIONS: Periodontal disease might increase the risk for pancreatic cancer. Moreover, increased levels of antibodies against specific commensal oral bacteria, which can inhibit growth of pathogenic bacteria, might reduce the risk of pancreatic cancer. Studies are needed to determine whether oral bacteria have direct effects on pancreatic cancer pathogenesis or serve as markers of the immune response. |
| first_indexed | 2024-03-06T20:48:37Z |
| format | Journal article |
| id | oxford-uuid:36cb8d67-af18-42e3-b92b-3ea726b90c5f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:48:37Z |
| publishDate | 2013 |
| record_format | dspace |
| spelling | oxford-uuid:36cb8d67-af18-42e3-b92b-3ea726b90c5f2022-03-26T13:40:08ZPlasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:36cb8d67-af18-42e3-b92b-3ea726b90c5fEnglishSymplectic Elements at Oxford2013Michaud, DIzard, JWilhelm-Benartzi, CYou, DGrote, VTjønneland, ADahm, COvervad, KJenab, MFedirko, VBoutron-Ruault, MClavel-Chapelon, FRacine, AKaaks, RBoeing, HFoerster, JTrichopoulou, ALagiou, PTrichopoulos, DSacerdote, CSieri, SPalli, DTumino, RPanico, SSiersema, POBJECTIVE: Examine the relationship between antibodies to 25 oral bacteria and pancreatic cancer risk in a prospective cohort study. DESIGN: We measured antibodies to oral bacteria in prediagnosis blood samples from 405 pancreatic cancer cases and 416 matched controls, nested within the European Prospective Investigation into Cancer and Nutrition study. Analyses were conducted using conditional logistic regression and additionally adjusted for smoking status and body mass index. RESULTS: Individuals with high levels of antibodies against Porphyromonas gingivalis ATTC 53978, a pathogenic periodontal bacteria, had a twofold higher risk of pancreatic cancer than individuals with lower levels of these antibodies (OR 2.14; 95% CI 1.05 to 4.36; >200 ng/ml vs ≤200 ng/ml). To explore the association with commensal (non-pathogenic) oral bacteria, we performed a cluster analysis and identified two groups of individuals, based on their antibody profiles. A cluster with overall higher levels of antibodies had a 45% lower risk of pancreatic cancer than a cluster with overall lower levels of antibodies (OR 0.55; 95% CI 0.36 to 0.83). CONCLUSIONS: Periodontal disease might increase the risk for pancreatic cancer. Moreover, increased levels of antibodies against specific commensal oral bacteria, which can inhibit growth of pathogenic bacteria, might reduce the risk of pancreatic cancer. Studies are needed to determine whether oral bacteria have direct effects on pancreatic cancer pathogenesis or serve as markers of the immune response. |
| spellingShingle | Michaud, D Izard, J Wilhelm-Benartzi, C You, D Grote, V Tjønneland, A Dahm, C Overvad, K Jenab, M Fedirko, V Boutron-Ruault, M Clavel-Chapelon, F Racine, A Kaaks, R Boeing, H Foerster, J Trichopoulou, A Lagiou, P Trichopoulos, D Sacerdote, C Sieri, S Palli, D Tumino, R Panico, S Siersema, P Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. |
| title | Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. |
| title_full | Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. |
| title_fullStr | Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. |
| title_full_unstemmed | Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. |
| title_short | Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. |
| title_sort | plasma antibodies to oral bacteria and risk of pancreatic cancer in a large european prospective cohort study |
| work_keys_str_mv | AT michaudd plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT izardj plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT wilhelmbenartzic plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT youd plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT grotev plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT tjønnelanda plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT dahmc plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT overvadk plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT jenabm plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT fedirkov plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT boutronruaultm plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT clavelchapelonf plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT racinea plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT kaaksr plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT boeingh plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT foersterj plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT trichopouloua plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT lagioup plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT trichopoulosd plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT sacerdotec plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT sieris plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT pallid plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT tuminor plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT panicos plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy AT siersemap plasmaantibodiestooralbacteriaandriskofpancreaticcancerinalargeeuropeanprospectivecohortstudy |